Biological drugs (biologics), such as antibodies, proteins, and viruses, are some of the most effective modern disease treatments. These therapeutics are manufactured in cells, so they run the risk of containing product- and process-related impurities that may affect a drug’s safety profile. Scientists purify these biologics using innovative chromatography-based workflows that facilitate high drug purity and yield.
Download this ebook from Bio-Rad to learn about
- Efficient purification workflows for IgGs, IgMs, and large biomolecules
- Methods for refinining biosimilar production at scale
- Design of Experiment (DoE) approaches for method optimization
